The primary purpose of the HIRF is to conduct and support scientific research in connection with finding a cure for various forms of cancer, particularly with the use of immunotherapy. Its mission also is to develop a highly sophisticated database and network system for the collection and dissemination of valuable data from cancer research and treatment throughout the world. Currently, HIRF is preparing to support cancer research and related program/activities in the United States, Japan, Bulgaria, Germany, and Malaysia.
Hasumi International Research Foundation (HIRF) was incorporated as a nonprofit organization in 2019, in Washington, DC, under the laws of the District of Columbia of the United States of America. The HIRF has applied and intends to qualify as a tax exempt organization as specified in Section 501(c)3 of the Internal Revenue Code. The HIRF will be seeking support from public and private sources to further its cancer research program and activities